$5.27 +0.17 (3.33%) Merrimack Pharmaceuticals Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 5.27
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: +0.17 (3.33%)
Prev Close: 5.10
Open: 5.11
Bid: 5.26
Ask: 5.27
  1. Morning Call For Thursday, Nov. 10

    TalkMarkets | Nov. 10, 2016 | 09:03AM EST
  2. Merrimack Amends MM-121 Phase 2 Clinical Study in Heregulin-Positive Non-Small Cell Lung Cancer to Support Potential Registration

    Benzinga | Dec. 22, 2015 | 16:17PM EST
  3. Merrimack and Baxalta Announce Publication of the ONIVYDEâ„¢ (irinotecan liposome injection) NAPOLI-1 Study in The Lancet

    Benzinga | Nov. 23, 2015 | 08:03AM EST
  4. PharmaEngine Announces FDA Approves Merrimack's ONIVYDE

    Benzinga | Oct. 23, 2015 | 03:22AM EST
  5. Merrimack Comfirms U.S. FDA Approval of ONIVYDE(TM) (irinotecan liposome injection) for the Treatment of Patients with Metastatic Pancreatic Cancer

    Benzinga | Oct. 22, 2015 | 12:12PM EST
  6. U.S. FDA Grants Priority Review for MM-398 New Drug Application

    Benzinga | Jun. 25, 2015 | 06:05AM EST
  7. Benzinga's Top Initiations

    Benzinga | May. 13, 2015 | 08:17AM EST
  8. First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients

    Benzinga | Apr. 21, 2015 | 07:03AM EST
  9. Merrimack Pharma Reports Final Clinical Results for MM-302 Phase 1 Study

    Benzinga | Apr. 20, 2015 | 15:01PM EST
  10. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  11. Weekly CEO Sells Highlight: Starbucks Corp, KD Supply Holdings Inc, Capital One Financial Corp, ...

    GuruFocus | Dec. 14, 2014 | 21:57PM EST
  12. Top 5 Biotech Stocks Over The Past Year

    Benzinga | Oct. 6, 2014 | 13:28PM EST
  13. Merrimack Pharmaceuticals

    IBD | Sep. 30, 2014 | 17:37PM EST
  14. Stocks Gain While Dollar Reaches Highest Level Since 2010

    Benzinga | Sep. 24, 2014 | 16:03PM EST
  15. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat Results

    Benzinga | Sep. 24, 2014 | 14:54PM EST
Trading Center